n-2-hexyl-n-methylpropargylamine has been researched along with pargyline in 2 studies
Studies (n-2-hexyl-n-methylpropargylamine) | Trials (n-2-hexyl-n-methylpropargylamine) | Recent Studies (post-2010) (n-2-hexyl-n-methylpropargylamine) | Studies (pargyline) | Trials (pargyline) | Recent Studies (post-2010) (pargyline) |
---|---|---|---|---|---|
9 | 0 | 0 | 2,811 | 27 | 295 |
Protein | Taxonomy | n-2-hexyl-n-methylpropargylamine (IC50) | pargyline (IC50) |
---|---|---|---|
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.535 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 2.8888 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.5031 | |
Renin | Callithrix jacchus (white-tufted-ear marmoset) | 2.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boulton, AA; Davis, BA; Yu, PH | 1 |
Lai, CT; Yu, PH | 1 |
1 review(s) available for n-2-hexyl-n-methylpropargylamine and pargyline
Article | Year |
---|---|
Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Mice; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Structure-Activity Relationship | 1995 |
1 other study(ies) available for n-2-hexyl-n-methylpropargylamine and pargyline
Article | Year |
---|---|
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Dopamine; Drug Synergism; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Pargyline; Propylamines; Reactive Oxygen Species; Selegiline; Tumor Cells, Cultured | 1997 |